NDC 13744-505-32 - MELOXIDYL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13744-505
- Requested NDC
- 13744-505-32
- Package NDCs from labels
- 13744-505-01, 13744-505-32, 13744-505-10, 13744-505-20
- Manufacturer
- Ceva Sante Animale
- Effective date
- 2026-11-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MELOXIDYL - Ceva Sante Animale | Ceva Sante Animale | 2026-11-17 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13744-505-01 | MELOXIDYL | 10 mL in 1 BOTTLE | SUSPENSION | 10 | 8 | |
| 13744-505-01 | MELOXIDYL | 1 in 1 CARTON | SUSPENSION | 1 | 8 | |
| 13744-505-10 | MELOXIDYL | 100 mL in 1 BOTTLE | SUSPENSION | 100 | 8 | |
| 13744-505-10 | MELOXIDYL | 1 in 1 CARTON | SUSPENSION | 1 | 8 | |
| 13744-505-20 | MELOXIDYL | 1 in 1 CARTON | SUSPENSION | 1 | 8 | |
| 13744-505-20 | MELOXIDYL | 200 mL in 1 BOTTLE | SUSPENSION | 200 | 8 | |
| 13744-505-32 | MELOXIDYL | 1 in 1 CARTON | SUSPENSION | 1 | 8 | |
| 13744-505-32 | MELOXIDYL | 32 mL in 1 BOTTLE | SUSPENSION | 32 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MELOXICAM | ACTIVE INGREDIENT | VG2QF83CGL | MELOXIDYL (MELOXICAM) SUSPENSION [CEVA SANTE ANIMALE] | 2 | |
| MELOXICAM | ACTIVE MOIETY | VG2QF83CGL | MELOXIDYL (MELOXICAM) SUSPENSION [CEVA SANTE ANIMALE] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| meloxicam | MELOXICAM | QPharma, Inc. | 20ec4646-9d1c-41c9-93f6-754b3a4f234f | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | A-S Medication Solutions | 67974608-326e-4e62-8430-6fbc14d1d69b | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | NuCare Pharmaceuticals,Inc. | 87ef5a9b-2dd1-2ef9-e053-2995a90a5149 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | QPharma, Inc. | 14e7472a-24fe-4ae1-abc7-c2972ce8cd74 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | A-S Medication Solutions | 11984306-9b71-4c2a-81bc-8942966810be | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | PHOENIX RX LLC | 3ff222f1-3fe2-9591-e063-6394a90a349f | 2025-09-29 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | American Health Packaging | 937ea2ca-6b8c-4c80-9926-f4de7c8f5643 | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Lupin Pharmaceuticals, Inc. | 43e2b0f3-cf34-4f51-aa93-39ed98cab449 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | AvPAK | ee8df8fa-d08a-8c8b-f048-813e5022a101 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | PHOENIX RX LLC | 3ede6724-d9be-5b44-e063-6294a90afbaa | 2025-09-15 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | Cipla USA Inc. | bb83cd61-0a82-4fe0-b72e-5b715cbd656d | 2025-09-10 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | PHOENIX RX LLC | 3b1938e5-7a9e-b214-e063-6394a90a1270 | 2025-08-13 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| XIFYRM | MELOXICAM | Azurity Pharmaceuticals, Inc. | bf2b198c-0726-488a-b911-4fe394e4b56e | 2025-06-18 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | ANI Pharmaceuticals, Inc. | ce9a8fd7-9bd2-4793-82f3-0fb8f0965d0f | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | Asclemed USA, Inc. | 6d7ede5a-c12e-4979-a47a-f3346ea5bc80 | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Carlsbad Technology, Inc. | 20871c7f-1e36-49ef-8e2b-70112430ca1e | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | d3182622-4b9b-4850-bf9f-108c5610eb40 | 2025-04-01 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | ed9c8c21-1d08-4afa-9cd2-3fd8b2a83baf | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 75af3e09-f510-45a4-9f21-50bff7aa5510 | 2025-03-21 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 218e71c6-265a-45f4-b660-5c1da5a36bd2 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.